Loading...

Julie Sutcliffe

Title(s)Professor, Hematology and Oncology
SchoolUniversity of California, Davis
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Tang YSC, Davis RA, Ganguly T, Sutcliffe JL. Identification, Characterization, and Optimization of Integrin avß6-Targeting Peptides from a One-Bead One-Compound (OBOC) Library: Towards the Development of Positron Emission Tomography (PET) Imaging Agents. Molecules. 2019 Jan 16; 24(2). PMID: 30654483.
      View in: PubMed
    2. Hausner SH, Bold RJ, Cheuy LY, Chew HK, Daly ME, Davis RA, Foster CC, Kim EJ, Sutcliffe JL. Preclinical Development and First-in-Human Imaging of the Integrin avß6 with [18F]avß6-Binding Peptide in Metastatic Carcinoma. Clin Cancer Res. 2019 Feb 15; 25(4):1206-1215. PMID: 30401687.
      View in: PubMed
    3. White JB, Hu LY, Boucher DL, Sutcliffe JL. ImmunoPET Imaging of avß6 Expression Using an Engineered Anti-avß6 Cys-diabody Site-Specifically Radiolabeled with Cu-64: Considerations for Optimal Imaging with Antibody Fragments. Mol Imaging Biol. 2018 02; 20(1):103-113. PMID: 28653240.
      View in: PubMed
    4. Abu Aboud O, Habib SL, Trott J, Stewart B, Liang S, Chaudhari AJ, Sutcliffe J, Weiss RH. Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging. Cancer Res. 2017 12 01; 77(23):6746-6758. PMID: 29021138.
      View in: PubMed
    5. Davis RA, Rippner DA, Hausner SH, Parikh SJ, McElrone AJ, Sutcliffe JL. In Vivo Tracking of Copper-64 Radiolabeled Nanoparticles in Lactuca sativa. Environ Sci Technol. 2017 Nov 07; 51(21):12537-12546. PMID: 28954194.
      View in: PubMed
    6. Moore A, Menkens A, Sutcliffe J. WIMIN: Who We Are and What We Do. Mol Imaging Biol. 2017 06; 19(3):328-331. PMID: 28255841.
      View in: PubMed
    7. Hu LY, Kelly KA, Sutcliffe JL. High-Throughput Approaches to the Development of Molecular Imaging Agents. Mol Imaging Biol. 2017 04; 19(2):163-182. PMID: 27812924.
      View in: PubMed
    8. Davis RA, Lau K, Hausner SH, Sutcliffe JL. Solid-phase synthesis and fluorine-18 radiolabeling of cycloRGDyK. Org Biomol Chem. 2016 Sep 21; 14(37):8659-8663. PMID: 27714190.
      View in: PubMed
    9. Olberg DE, Bauer N, Andressen KW, Hjørnevik T, Cumming P, Levy FO, Klaveness J, Haraldsen I, Sutcliffe JL. Brain penetrant small molecule (18)F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats. Nucl Med Biol. 2016 08; 43(8):478-89. PMID: 27236283.
      View in: PubMed
    10. White JB, Boucher DL, Zettlitz KA, Wu AM, Sutcliffe JL. Development and characterization of an avß6-specific diabody and a disulfide-stabilized avß6-specific cys-diabody. Nucl Med Biol. 2015 Dec; 42(12):945-57. PMID: 26341848.
      View in: PubMed
    11. Hausner SH, Bauer N, Hu LY, Knight LM, Sutcliffe JL. The Effect of Bi-Terminal PEGylation of an Integrin avß6-Targeted ¹8F Peptide on Pharmacokinetics and Tumor Uptake. J Nucl Med. 2015 May; 56(5):784-90. PMID: 25814519.
      View in: PubMed
    12. Mejía Oneto JM, Gupta M, Leach JK, Lee M, Sutcliffe JL. Implantable biomaterial based on click chemistry for targeting small molecules. Acta Biomater. 2014 Dec; 10(12):5099-5105. PMID: 25162537.
      View in: PubMed
    13. Hu LY, Bauer N, Knight LM, Li Z, Liu S, Anderson CJ, Conti PS, Sutcliffe JL. Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin avß 6. Mol Imaging Biol. 2014 Aug; 16(4):567-77. PMID: 24448825.
      View in: PubMed
    14. Satpati D, Hausner SH, Bauer N, Sutcliffe JL. Cerenkov luminescence imaging of av ß6 integrin expressing tumors using (90) Y-labeled peptides. J Labelled Comp Radiopharm. 2014 Jul; 57(9):558-65. PMID: 25042833.
      View in: PubMed
    15. Shin DS, You J, Rahimian A, Vu T, Siltanen C, Ehsanipour A, Stybayeva G, Sutcliffe J, Revzin A. Photodegradable hydrogels for capture, detection, and release of live cells. Angew Chem Int Ed Engl. 2014 Jul 28; 53(31):8221-4. PMID: 24931301.
      View in: PubMed
    16. Olberg DE, Andressen KW, Levy FO, Klaveness J, Haraldsen I, Sutcliffe JL. Synthesis and in vitro evaluation of small-molecule [18F] labeled gonadotropin-releasing hormone (GnRH) receptor antagonists as potential PET imaging agents for GnRH receptor expression. Bioorg Med Chem Lett. 2014 Apr 01; 24(7):1846-50. PMID: 24613701.
      View in: PubMed
    17. Griessinger CM, Kehlbach R, Bukala D, Wiehr S, Bantleon R, Cay F, Schmid A, Braumüller H, Fehrenbacher B, Schaller M, Eichner M, Sutcliffe JL, Ehrlichmann W, Eibl O, Reischl G, Cherry SR, Röcken M, Pichler BJ, Kneilling M. In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue. J Nucl Med. 2014 Feb; 55(2):301-7. PMID: 24434289.
      View in: PubMed
    18. Hausner SH, Bauer N, Sutcliffe JL. In vitro and in vivo evaluation of the effects of aluminum [¹8F]fluoride radiolabeling on an integrin avß6-specific peptide. Nucl Med Biol. 2014 Jan; 41(1):43-50. PMID: 24267053.
      View in: PubMed
    19. Siltanen C, Shin DS, Sutcliffe J, Revzin A. Micropatterned photodegradable hydrogels for the sorting of microbeads and cells. Angew Chem Int Ed Engl. 2013 Aug 26; 52(35):9224-8. PMID: 23868693.
      View in: PubMed
    20. Hausner SH, Carpenter RD, Bauer N, Sutcliffe JL. Evaluation of an integrin avß6-specific peptide labeled with [18F]fluorine by copper-free, strain-promoted click chemistry. Nucl Med Biol. 2013 Feb; 40(2):233-9. PMID: 23265667.
      View in: PubMed
    21. White JB, Hausner SH, Carpenter RD, Sutcliffe JL. Optimization of the solid-phase synthesis of [18F] radiolabeled peptides for positron emission tomography. Appl Radiat Isot. 2012 Dec; 70(12):2720-9. PMID: 23041391.
      View in: PubMed
    22. Davison HR, Taylor S, Drake C, Phuan PW, Derichs N, Yao C, Jones EF, Sutcliffe J, Verkman AS, Kurth MJ. Functional fluorescently labeled bithiazole ?F508-CFTR corrector imaged in whole body slices in mice. Bioconjug Chem. 2011 Dec 21; 22(12):2593-9. PMID: 22034937.
      View in: PubMed
    23. Carpenter RD, Hausner SH, Sutcliffe JL. Copper-Free Click for PET: Rapid 1,3-Dipolar Cycloadditions with a Fluorine-18 Cyclooctyne. ACS Med Chem Lett. 2011 Dec 08; 2(12):885-9. PMID: 24900276.
      View in: PubMed
    24. Shin DS, Seo JH, Sutcliffe JL, Revzin A. Photolabile micropatterned surfaces for cell capture and release. Chem Commun (Camb). 2011 Nov 21; 47(43):11942-4. PMID: 21970983.
      View in: PubMed
    25. Sutcliffe JL. Nanomedicine explored at molecular imaging summit. Mol Imaging. 2011 Feb; 10(1):1. PMID: 21303610.
      View in: PubMed
    26. Gagnon MK, Hausner SH, Marik J, Abbey CK, Marshall JF, Sutcliffe JL. High-throughput in vivo screening of targeted molecular imaging agents. Proc Natl Acad Sci U S A. 2009 Oct 20; 106(42):17904-9. PMID: 19815497.
      View in: PubMed
    27. Strickland LA, Ross J, Williams S, Ross S, Romero M, Spencer S, Erickson R, Sutcliffe J, Verbeke C, Polakis P, van Bruggen N, Koeppen H. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. J Pathol. 2009 Jul; 218(3):380-90. PMID: 19334050.
      View in: PubMed
    28. Hausner SH, Abbey CK, Bold RJ, Gagnon MK, Marik J, Marshall JF, Stanecki CE, Sutcliffe JL. Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res. 2009 Jul 15; 69(14):5843-50. PMID: 19549907.
      View in: PubMed
    29. Denardo SJ, Liu R, Albrecht H, Natarajan A, Sutcliffe JL, Anderson C, Peng L, Ferdani R, Cherry SR, Lam KS. 111In-LLP2A-DOTA Polyethylene Glycol-Targeting {alpha}4{beta}1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies. J Nucl Med. 2009 Apr; 50(4):625-34. PMID: 19289419.
      View in: PubMed
    30. Hausner SH, Kukis DL, Gagnon MK, Stanecki CE, Ferdani R, Marshall JF, Anderson CJ, Sutcliffe JL. Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide. Mol Imaging. 2009 Mar-Apr; 8(2):111-21. PMID: 19397856.
      View in: PubMed
    31. Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU, Gandour-Edwards R, Chuang FY, Bold RJ, Kung HJ. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res. 2009 Jan 15; 69(2):700-8. PMID: 19147587.
      View in: PubMed
    32. Martin SM, O'Donnell RT, Kukis DL, Abbey CK, McKnight H, Sutcliffe JL, Tuscano JM. Imaging and pharmacokinetics of (64)Cu-DOTA-HB22.7 administered by intravenous, intraperitoneal, or subcutaneous injection to mice bearing non-Hodgkin's lymphoma xenografts. Mol Imaging Biol. 2009 Mar-Apr; 11(2):79-87. PMID: 18949521.
      View in: PubMed
    33. Hausner SH, Marik J, Gagnon MK, Sutcliffe JL. In vivo positron emission tomography (PET) imaging with an alphavbeta6 specific peptide radiolabeled using 18F-"click" chemistry: evaluation and comparison with the corresponding 4-[18F]fluorobenzoyl- and 2-[18F]fluoropropionyl-peptides. J Med Chem. 2008 Oct 09; 51(19):5901-4. PMID: 18785727.
      View in: PubMed
    34. Parsons CM, Sutcliffe JL, Bold RJ. Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg. 2008; 15(4):429-35. PMID: 18670846.
      View in: PubMed
    35. Zhang H, Kusunose J, Kheirolomoom A, Seo JW, Qi J, Watson KD, Lindfors HA, Ruoslahti E, Sutcliffe JL, Ferrara KW. Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model. Biomaterials. 2008 Apr; 29(12):1976-88. PMID: 18255141.
      View in: PubMed
    36. Huang J, Lee CC, Sutcliffe JL, Cherry SR, Tarantal AF. Radiolabeling rhesus monkey CD34+ hematopoietic and mesenchymal stem cells with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for microPET imaging. Mol Imaging. 2008 Jan-Feb; 7(1):1-11. PMID: 18384718.
      View in: PubMed
    37. Aina OH, Liu R, Sutcliffe JL, Marik J, Pan CX, Lam KS. From combinatorial chemistry to cancer-targeting peptides. Mol Pharm. 2007 Sep-Oct; 4(5):631-51. PMID: 17880166.
      View in: PubMed
    38. Hausner SH, DiCara D, Marik J, Marshall JF, Sutcliffe JL. Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin alphavbeta6 expression with positron emission tomography. Cancer Res. 2007 Aug 15; 67(16):7833-40. PMID: 17699789.
      View in: PubMed
    39. Marik J, Tartis MS, Zhang H, Fung JY, Kheirolomoom A, Sutcliffe JL, Ferrara KW. Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP). Nucl Med Biol. 2007 Feb; 34(2):165-71. PMID: 17307124.
      View in: PubMed
    40. DiCara D, Rapisarda C, Sutcliffe JL, Violette SM, Weinreb PH, Hart IR, Howard MJ, Marshall JF. Structure-function analysis of Arg-Gly-Asp helix motifs in alpha v beta 6 integrin ligands. J Biol Chem. 2007 Mar 30; 282(13):9657-65. PMID: 17244604.
      View in: PubMed
    41. Marik J, Sutcliffe JL. Fully automated preparation of n.c.a. 4-[18F]fluorobenzoic acid and N-succinimidyl 4-[18F]fluorobenzoate using a Siemens/CTI chemistry process control unit (CPCU). Appl Radiat Isot. 2007 Feb; 65(2):199-203. PMID: 16935516.
      View in: PubMed
    42. Marik J, Hausner SH, Fix LA, Gagnon MK, Sutcliffe JL. Solid-phase synthesis of 2-[18F]fluoropropionyl peptides. Bioconjug Chem. 2006 Jul-Aug; 17(4):1017-21. PMID: 16848410.
      View in: PubMed
    43. Bingham EM, Dunn JT, Smith D, Sutcliffe-Goulden J, Reed LJ, Marsden PK, Amiel SA. Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study. Diabetologia. 2005 Oct; 48(10):2080-9. PMID: 16143864.
      View in: PubMed
    44. Dearling JL, Flynn AA, Sutcliffe-Goulden J, Petrie IA, Boden R, Green AJ, Boxer GM, Begent RH, Pedley RB. Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. J Nucl Med. 2004 Jan; 45(1):101-7. PMID: 14734681.
      View in: PubMed
    45. Sutcliffe-Goulden JL, O'Doherty MJ, Marsden PK, Hart IR, Marshall JF, Bansal SS. Rapid solid phase synthesis and biodistribution of 18F-labelled linear peptides. Eur J Nucl Med Mol Imaging. 2002 Jun; 29(6):754-9. PMID: 12029548.
      View in: PubMed
    46. Sutcliffe-Goulden JL, O'Doherty MJ, Bansal SS. Solid phase synthesis of [18F]labelled peptides for positron emission tomography. Bioorg Med Chem Lett. 2000 Jul 17; 10(14):1501-3. PMID: 10915036.
      View in: PubMed
    47. Marsden P, Sutcliffe-Goulden J. Principles and technology of PET scanning. Nucl Med Commun. 2000 Mar; 21(3):221-4. PMID: 10823321.
      View in: PubMed
    48. Badawi RD, Marsden PK, Cronin BF, Sutcliffe JL, Maisey MN. Optimization of noise-equivalent count rates in 3D PET. Phys Med Biol. 1996 Sep; 41(9):1755-76. PMID: 8884911.
      View in: PubMed